Evidence map›Paper›PMID 8544140›Full record

ArticleThe Journal of physiology1995

Roles of arachidonic acid, lipoxygenases and phosphatases in calcium-dependent modulation of M-current in bullfrog sympathetic neurons.

S P Yu

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. Polyunsaturated Fatty Acids as Modulators of KFrontiers in physiology · 2020
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Arachidonic acid and ion channels: an update.British journal of pharmacology · 2008
    Review
  7. Article
  8. M1 muscarinic receptors inhibit L-type Ca2+ current and M-current by divergent signal transduction cascades.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
  9. Multiple channel interactions explain the protection of sympathetic neurons from apoptosis induced by nerve growth factor deprivation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2002
    Article
  10. 12-hydroxyeicosatetrenoate (12-HETE) attenuates AMPA receptor-mediated neurotoxicity: evidence for a G-protein-coupled HETE receptor.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2002
    Article
  11. Article
  12. Article
  13. Bradykinin inhibits M current via phospholipase C and Ca2+ release from IP3-sensitive Ca2+ stores in rat sympathetic neurons.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

S P YuHoward Hughes Medical Institute, Department of Neurobiology and Behavior, State University of New York at Stony Brook 11794, USA.
Howard Hughes Medical Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1. M-current (IM) is regulated by intracellular free Ca2+ ([Ca2+]i). Suppression and overrecovery of IM induced by muscarine and luteinizing-hormone releasing hormone (LHRH) are also regulated by [Ca2+]i. The role of the arachidonic acid (AA) pathway in the Ca(2+)-dependent modulation of IM was investigated using whole-cell voltage clamp and intracellular perfusion in dissociated bullfrog sympathetic B neurons. 2. Quinacrine (10-20 microM) and 4-bromophenacyl bromide (4-BPB; 4-10 microM), the inhibitors of phospholipase A2, blocked the enhancement of IM evoked by raising [Ca2+]i. 3. AA (6-120 microM) increased IM by about 50% of the control current in a Ca(2+)-dependent manner. 4. Enhancements of IM by Ca2+ and AA were blocked by the lipoxygenase (LO) inhibitors nordihydroguaiaretic acid (NDGA; 1-5 microM) and 5,8,11-eicosatrynoic acid (ETI; 10 microM). The cyclo-oxygenase inhibitor indomethacin (10 microM) had no effect. 5. Enhancement of IM by Ca2+ was abolished by the selective 12-LO inhibitors baicalein (1-2 microM) and 15(S)-hydroxy-5-cis-8-cis-11-cis-13-trans-eicosatetraenoic acid (15-HETE; 6.5 microM). A 12-LO product, 2(S)-hydroxy-5-cis-8-cis-10-trans-14-cis- eicosatetraenoic acid (12-HETE; 13-20 microM), increased IM without Ca2+ requirement. 6. Enhancement of IM by Ca2+ was not affected by the selective 5-LO inhibitors AA-861 (10 microM), 5,6-dehydroarachidonic acid (5,6-DAA, 10 microM) and L-651,896 (10 microM). The 5-LO metabolites leukotriene C4 (1.5-8 microM) and leukotriene B4 (1.5-5 microM) showed no obvious effect on IM. 7. NDGA alone inhibited IM with an IC50 of 0.73 microM at 120 nM Cai(2+). 8. NDGA did not affect suppression of IM by muscarine or LHRH; however, overrecovery of IM upon removing these agonists was totally eliminated by 1 microM NDGA. 9. Inhibitors of phosphatases, calyculin A (0.1 microM) and okadaic acid (1 microM), completely abolished overrecovery of IM. Calyculin A also blocked the Ca(2+)-induced IM enhancement. 10. It is suggested that Ca2+ enhances IM by stimulating the AA metabolic pathway. Dephosphorylation probably upregulates IM. Overrecovery of IM is probably a result of stimulation of the LO pathway and phosphatases by increased [Ca2+]i.

Indexed as

AnimalsArachidonic AcidCalciumCell MembraneCyclooxygenase InhibitorsGanglia, SympatheticIn Vitro TechniquesLipoxygenaseLipoxygenase InhibitorsNeuronsPhosphoric Monoester HydrolasesPotassium ChannelsRana catesbeianaReceptors, MuscarinicSympathetic Nervous SystemArachidonic AcidCalciumCyclooxygenase InhibitorsLipoxygenaseLipoxygenase InhibitorsPhosphoric Monoester HydrolasesPotassium ChannelsReceptors, Muscarinic

Identifiers

PMID8544140
PMCPMC1156664
OpenAlexW2022461781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.